PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-13

Date Title Company
13-Dec-2022 Suture Anchor Devices Market Trends: Development is Changing Business Needs MARKITWIRED
13-Dec-2022 Single-Photon Emission Computed Tomography Market Trends and Growth Forecast by 2032 MARKITWIRED
13-Dec-2022 Breast Pump Market Will Generate Booming Growth Opportunities to 2030 | FMI MARKITWIRED
13-Dec-2022 Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program Businesswire
13-Dec-2022 ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others Businesswire
13-Dec-2022 Empyrean Neuroscience Forms Scientific Advisory Board Businesswire
13-Dec-2022 No Opioids After Surgery: Evonik Invests in Allay Therapeutics and Supplies Key Technology for Pain Therapy Implants Businesswire
13-Dec-2022 Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics Businesswire
13-Dec-2022 Curebase Releases Diagnostic Offering that Delivers First All-Inclusive Package of Software and Services Needed to Fully Execute Diagnostic Studies Curebase
13-Dec-2022 Scottish Medicines Consortium (SMC) Extends Advice Accepting RINVOQ®▼(upadacitinib) For Treatment of Adults with Moderate Rheumatoid Arthritis AbbVie
13-Dec-2022 Abingworth appoints experienced life sciences investor Joy Ghosh, PhD as Managing Director Abingworth
13-Dec-2022 Oxford Science Enterprises’ Portfolio Company OxfordVR to Combine with BehaVR to Confront the Mental Health Crisis with the Largest VR Delivery Platform for Evidence-Based Digital Therapeutics Oxford Science Enterprises
13-Dec-2022 Global Glycomic Therapeutics Market Forecast to 2028 - Wide Applications of Glycomics in Therapeutics Presents Opportunities - ResearchAndMarkets.com Businesswire
13-Dec-2022 Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA® (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial Moderna
13-Dec-2022 Merck Global Health Innovation Fund and P74 Ventures Make Strategic Investment in TransVoyant for Intelligent, ‘Self Aware’ Supply Chain Platform  Businesswire
13-Dec-2022 CluePoints Appoints Andy Cooper as New Chief Executive Officer CluePoints
13-Dec-2022 Glenmark’s antimalarial wins Highly Commended at Pharmacy MVP Awards Glenmark
13-Dec-2022 The Worldwide Aminophenol Industry is Projected to Reach $1.7 Billion by 2027 - ResearchAndMarkets.com Businesswire
13-Dec-2022 PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference PureTech
13-Dec-2022 NEW 3D-PRINTING MATERIAL AND FASTEST HIGH PRECISION PRINTER CREATE HUMAN BODY-LIKE MICRO-ENVIRONMENT UpNano